Back to Trades
Aprea Therapeutics, Inc.
APRECIK: 0001781983
Follow APRE
Track Aprea Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.
Aprea Therapeutics, Inc. (APRE) has recorded 12 insider filings from 10 unique insiders, totaling $196.5K in trading activity (net buying). Insiders have purchased $5.1K and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Gilad Oren. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$196.5K
Purchases
$5.1K
Sales
$0
Unique Insiders
10
Recent Insider Trades
12 loaded
| Jun 17 | APRE Aprea Therapeutics, Inc. | Gruia Gabriela | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | BIZZARI JEAN-PIERRE | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | Pamukcu Rifat | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | Seizinger Bernd R. | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | Peters Richard | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | Grissinger Michael | Director | Grant | $0 |
| Jun 17 | APRE Aprea Therapeutics, Inc. | Duey Marc | Director | Grant | $0 |
| Apr 1 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Other | $0 |
| Mar 16 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Grant | $0 |
| Mar 16 | APRE Aprea Therapeutics, Inc. | Gilad Oren | President/CEO, Director | Grant | $0 |
| Feb 2 | APRE Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Buy | $5.1K |
12 filings